Taurine and Skeletal Muscle Disorders

Neurochemical Research

Volumn 29, Issue 1, 2004, Pages 135-142

  Camerino, Diana Conte ^a,c   Tricarico, Domenico ^a   Pierno, Sabata ^a   Desaphy, Jean François ^a   Liantonio, Antonella ^a   Pusch, Michael ^b   Burdi, Rosa ^a   Camerino, Claudia ^a   Fraysse, Bodvael ^a   De Luca, Annamaria ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

^c Dipartimento Farmaco Chimico   (Italy)

Author keywords

Inherited and acquired myopathies; Skeletal muscle; Taurine; Therapeutic potential

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; ION CHANNEL; POTASSIUM CHANNEL; TAURINE;

AGING; CALCIUM HOMEOSTASIS; CHANNEL GATING; CHLORIDE CONDUCTANCE; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; GENETIC DISORDER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUSCLE ATROPHY; MUSCLE CONTRACTILITY; MUSCLE METABOLISM; MYOPATHY; NONHUMAN; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SARCOLEMMA; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; THOMSEN DISEASE;

AGING; ANIMALS; CALCIUM; HUMANS; MUSCULOSKELETAL DISEASES; TAURINE;

EID: 10744219513     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000010442.89826.9c     Document Type: Review

References (56)

1. Huxtable, R. J., 1992. The physiological actions of taurine. Physiol. Rev. 72:101-163.
2. Schaffer, S., Takahashi K., and Azuma, J. 2000. Role of osmoregulation in the action of taurine. Amino Acids 19:527-546.
3. Pesantes-Morales, H., Quesada, O., and Morán, J. 1998. Taurine: An osmolyte in mammalian tissues. Adv. Exp. Med. Biol. 442:209-217.
4. Satoh, H. and Sperelakis, N. 1998. Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen. Pharmacol. 30:451-463.
5. De Luca, A., Pierno, S., Tricarico, D., Desaphy, J. F., Liantonio, A., Barbieri, M., Camerino, C., Montanari, L., and Conte Camerino, D. 2000. Taurine and skeletal muscle ion channels. Adv. Exp. Med. Biol. 483:45-56.
6. Jurkat-Rott, K., Lerche, H., and Lehmann-Horn, F. 2002. Skeletal muscle channelopathies. J. Neurol. 249:1493-1502.
7. Jentsch, T. J., Stein, V., Weinreich, F., and Zdebik, A. A. 2002. Molecular structure and physiological function of chloride channels. Physiol. Rev. 82:503-568.
8. Lehmann-Horn, F., Jurkat-Rott, K., and Rudel, R. 2002. Periodic paralysis: Understanding channelopathies. Curr. Neurol. Neurosci. Rep. 2:61-69.
9. Conte Camerino, D., Franconi, F., Mambrini, M., Bennardini, F., Failli, P., Bryant, S. H., and Giotti, A. 1987. The action of taurine on chloride conductance and excitability characteristics of rat striated fibers. Pharmacol. Res. Commun. 19:685-701.
10. Conte Camerino, D., De Luca, A., Mambrini, M., Ferrannini, E., Franconi, F., Giotti, S. H., and Bryant, S. H. 1989. The effects of taurine on pharmacologically induced myotonia. Muscle Nerve 12:898-904.
11. Pierno, S., Tricarico, D., De Luca, A., Campagna, F., Carotti, A., Casini, G., and Conte Camerino, D. 1994. Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: A structure-activity relationship investigation. Naunyn-Schmiedebergs Arch. Pharmacol. 349:416-421.
12. Liantonio, A., Accardi, A., Carbonara, G., Fracchiolla, G., Loiodice, F., Tortorella, P., Traverso, S., Guida, P., Pierno, S., De Luca, A., Conte Camerino, D., and Pusch, M. 2002. Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid. Mol. Pharmacol. 62:265-271.
13. Ptacek, L. 1998. The familial periodic paralyses and nondystrophic myotonias. Am. J. Med. 104:58-70.
14. + current by taurine in guinea pig ventricula myocytes. Gen. Pharmacol. 31:155-157.
15. Schanne, O. F. and Dumaine, R. 1992. Interaction of taurine with the fast Na-current in isolated rabbit myocytes. J. Pharmacol. Exp. Ther. 263:1233-1240.
16. De Luca, A., Natuzzi, F., Desaphy, J. F., Loni, G., Lentini, G., Franchini, C., Tortorella, V., and Conte Camerino, D. 2000. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels. Mol. Pharmacol. 57:268-277.
17. Durelli, L., Mutani, R., and Fassio, F. 1983. The treatment of myotonia: Evaluation of chronic oral taurine therapy. Neurology 33:599-603.
18. Regensteiner, J. G., Wolfel, E. E., Brass, E. P., Carry, M. R., Ringel, S. P., Hargarten, M. E., Stamm, E. R., and Hiatt W. R. 1993. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation 87:413-421.
19. Cruz, C. A. T., Massuda, C. A., Cherri, J., and Piccinato, C. E. 1997. Metabolic alterations of skeletal muscle during ischaemia and reperfusion. J. Cardiovasc. Surg. 38:473-477.
20. Ischida, T., Yarimizu, K., Gute, D. C., and Korthuis, R. J. 1997. Mechanisms of ischemic preconditioning. Shock 8:86-94.
21. Tricarico, D. and Conte Camerino, D. 1994. Effects of ischaemia and post-ischaemic reperfusion on the passive and active electrical parameters of rat skeletal muscle fibres. Pflügers Arch. 426: 44-50.
22. Tricarico D., Casini G., and Conte Camerino, D. 1995. Effects of high energy phosphates and L-arginine on the electrical parameters of ischaemic reperfused rat skeletal muscle fibers. Eur. J. Pharmacol. 287:17-25.
23. 2+) channels in the local abnormalities and hyperkalemia following the ischemia-reperfusion injury of rat skeletal muscle. Neuromuscul. Disord. 12:258-265.
24. Allo, S. N., Bagby, L., and Schaffer, S. W. 1997. Taurine depletion, a novel mechanism for cardioprotection from regional ischemia. Am. J. Physiol. 273:H1956-H1961.
25. Suleiman, M. S., Moffatt, A. C., Dihmis, W. C., Caputo, M., Hutter, J. A., Angelini, G. D., and Bryan, A. J. 1997. Effect of ischaemia and reperfusion on the intracellular concentration of taurine and glutamine in the hearth of patients undergoing artery surgery. Biochim. Biophys. Acta 1324:223-231.
26. Saransari, P. and Oja, S. S. 1998. Mechanism of ischemia-induced taurine release in mouse hippocampal slices. Brain Res. 807: 118-124.
27. Nanobashvili, J., Neumayer, C., Fugl, A., Punz, A., Blumer, R., Prager, M., Mittlbock, M., Gruber, H., Polterauer, P., Roth, E., Malinski, T., and Huk, I. 2003. Ischemia/reperfusion injury of skeletal muscle: Plasma taurine as a measure of tissue damage. Surgery 133:91-100.
28. Takahashi, K., Ohyabu, Y., Takahashi, K., Solodushko, V., Takatani, T., Itoh, T., Schaffer, S. W., and Azuma, J. 2003. Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. J. Cardiovasc. Pharmacol. 41:726-733.
29. Tricarico, D., Barbieri, M., and Conte Camerino D. 2000. Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor. Br. J. Pharmacol. 130:827-834.
30. 2+-activated potassium channels of rat skeletal muscle fibers. J. Pharmacol. Exp. Ther. 298:1167-1171.
31. - conductance of rat skeletal muscle. Eur. J. Pharmacol. 296: 215-222.
32. De Luca, A., Conte Camerino, D., Failli, P., Franconi, F., and Giotti, A. 1990. Effects of taurine on mammalian skeletal muscle fiber during development. Prog. Clin. Biol. Res. 351:163-173.
33. Pierno, S., De Luca, A., Camerino, C., Huxtable, R. J., and Conte Camerino, D. 1998. Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. J. Pharmacol. Exp. Ther. 286:1183-1190.
34. Pierno, S., De Luca, A., Beck, C. L., George, A. L., and Conte Camerino, D. 1999. Aging-associated down-regulation of ClC-1 expression in skeletal muscle: Phenotypic-independent relation to the decrease of chloride conductance. FEBS Lett. 449:12-16.
35. De Luca, A., Pierno, S., and Conte Camerino D. 1994. Pharmacological interventions for the changes of chloride channel conductance of aging rat skeletal muscle. Ann. NY Acad. Sci. 717: 180-188.
36. De Luca, A., Tricarico, D., Pierno, S., and Conte Camerino, D. 1994. Aging and chloride channel regulation in rat fast-twitch muscle fibers. Pflügers Arch. 427:80-85.
37. Li, Y.-P. and Lombardini, J. B. 1991. Inhibition by taurine of the phosphorylation of specific synaptosomal proteins in the rat cortex: Effects of taurine on the stimulation of calcium uptake in mitochondria and inhibition of phosphoinositide turnover. Brain Res. 553:89-96.
38. Huxtable, R. J. and Bressler, R. 1973. Effect of taurine on a muscle intracellular membrane. Biochim. Biophys. Acta 323: 573-583.
39. Bakker, A. J. and Berg, H. M. 2002. Effect of taurine on sarcoplasmic reticulum function and force in skinned fast-twitch skeletal muscle fibres of the rat. J. Physiol. 538:185-194.
40. Turinski, J. and Long, C. L. 1990. Free amino acids in muscle: Effect of muscle fiber population and denervation. Am. J. Physiol. 258:E485-E491.
41. Pierno, S., Desaphy, J. F., Liantonio, A., De Bellis, M., Bianco, G., De Luca, A., Frigeri, A., Nicchia, G. P., Svelto, M., Leoty, C., George, A. L., Jr, and Conte Camerino, D. 2002. Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain 125:1510-1521.
42. Frigeri, A., Nicchia, G. P., Verbavatz, J. M., Valenti, G., and Svelto, M. 1998. Expression of aquaporin-4 in fast-twitch fibers of mammalian skeletal muscle. J. Clin. Invest. 102:695-703.
43. Frigeri, A., Nicchia, G. P., Desaphy, J. F., Pierno, S., De Luca, A., Conte Camerino, D., and Svelto, M. 2001. Muscle loading modulates aquaporin-4 expression in skeletal muscle. FASEB J. 15: 1282-1284.
44. Schaffer, S. W., Punna, S., Duan, J., Harada, H., Hamaguchi, T., and Azuma, J. 1992. Mechanisms underlying physiological modulation of myocardial contraction by taurine. Adv. Exp. Biol. Med. 315:193-198.
45. Hoffman, E. P. and Dressman, D. 2001. Molecular pathophysiology and targeted therapeutics for muscular dystrophy. Trends Pharmacol. Sci. 22:465-470.
46. Vandebrouck, C., Martin, D., Colson-Van Schoor, M., Debaix, H., and Gailly, P. 2002. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J. Cell Biol. 158:1089-1096.
47. Engel, A. G., Yamamoto, M., and Fischbeck, K. H. 1994. Dystrophinopathies. Pages 1133-1187, in Engel, A. G. and Franzini-Armstrong, G. (eds.), Myology. New York: McGraw-Hill.
48. McIntosch, L., Granberg, K.-E., Brière, K. M., and Anderson, J. E. 1998. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair. NMR Biomed. 11:1-10.
49. De Luca, A., Pierno, S., Camerino, C., Huxtable, R. J., and Conte Camerino, D. 1998. Effect of taurine on excitation-contraction coupling of extensor digitorum longus muscle of dystrophic mdx mouse. Adv. Exp. Med. Biol. 442:115-119.
50. De Luca, A., Pierno, S., Liantonio, A., Cetrone, M., Camerino, C., Simonetti, S., Papadia, F., and Conte Camerino, D. 2001. Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine. Br. J. Pharmacol. 132:1047-1054.
51. De Luca, A., Pierno, S., Liantonio, A., Cetrone, M., Camerino, C., Fraysse, B., Mirabella, M., Servidei, S., Ruegg, U. T., and Conte Camerino, D. 2003. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J. Pharmacol. Exp. Ther. 304:453-463.
52. Porter, J. D., Khanna, S., Kaminski, H. J., Roa, J. S., Merriam, A. P., Richmonds, C. R., Leahy, P., Li, J., Guo, W., and Andrade, F. H. 2002. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Human Mol. Genet. 11:263-272.
53. Kontny, E., Szczepanska, K., Kowalczewski, J., Kurowska, M., Janicka, I., Marcinkiewicz, J., and Maslinski, W. 2000. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 43:2169-2177.
54. Matsuzaki, Y., Miyazaki, T., Miyakawa, S., Bouscarel, B., Ikegami, T., and Tanaka, N. 2002. Decreased taurine concentration in skeletal muscles after exercise for various durations. Med. Sci. Sports Exerc. 34:793-797.
55. Dawson, R., Jr., Biasetti, M., Messina, S., and Dominy, J. 2002. The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids 22:309-324.
56. Yatabe, Y., Miyakawa, S., Miyazaki, T., Matsuzaki, Y., and Ochiai, N. 2003. Effects of taurine administration in rat skeletal muscles on exercise. J. Orthop. Sci. 8:415-419.